Tectonic Therapeutic, Inc.
NASDAQ:TECXBiotechnology
Healthcare
$21.04 -0.96%
-$0.29 today
- Market cap
- $411.32M
- Beta
- 1.22
- P/E (TTM)
- -6.7
- EPS (TTM)
- -$4.45
52W Low $14.39High $36.03
Volume 0.17M
Average 0.20M
Income Statement
Follow revenue through to earnings.
Revenue
$0.00
FY 2025 · Annual
Operating Income
-$84.04M
FY 2025 · Annual
Net Income
-$74.15M
FY 2025 · Annual
Income Statement
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 | 0 | 0 |
| Gross Margin | — | — | — | — | — |
| Research & Development | 10.98M | 25.65M | 36.97M | 41.36M | 63.49M |
| Selling, General & Admin | 4.63M | 7.18M | 7.68M | 16.65M | 20.55M |
| Operating Expenses | 15.61M | 32.83M | 44.65M | 58.02M | 84.04M |
| Depreciation & Amortization | 364K | 1.01M | 1.48M | 1.65M | 1.38M |
| EBITDA | (8.12M) | (31.03M) | (41.19M) | (56.23M) | (71.48M) |
| EBITDA Margin | — | — | — | — | — |
| Operating Income | (15.61M) | (32.83M) | (44.65M) | (58.02M) | (84.04M) |
| Operating Margin | — | — | — | — | — |
| Interest Income | 0 | 149K | 581K | 4.26M | 11.3M |
| Interest Expense | 224K | 144K | 152K | 107K | 63K |
| Other Income / Expenses | 6.68M | 650K | 1.83M | 33K | 11.12M |
| Income Before Tax | (8.93M) | (32.18M) | (42.82M) | (57.98M) | (72.92M) |
| Pre-Tax Margin | — | — | — | — | — |
| Income Tax Expense | 0 | 0 | 0 | 0 | 1.23M |
| Net Income | (8.93M) | (32.18M) | (42.82M) | (57.98M) | (74.15M) |
| Net Margin | — | — | — | — | — |
| EPS (Basic) | (33.36) | (29.05) | (11.59) | (3.93) | (4.05) |
| EPS (Diluted) | (33.36) | (29.05) | (11.53) | (3.93) | (4.05) |
| 3.57M | 3.64M | 3.69M | 14.77M | 18.32M | |
| 3.57M | 3.64M | 3.71M | 14.77M | 18.32M |
TECX Earnings Waterfall · TTM
NASDAQ:TECX · Revenue to Net Income
Key Ratios
EPS$-4.46
Gross Margin0.0%
Net Margin0.0%
P/E Ratio-4.8
P/S Ratio0.0
Analysis
$0 of revenue converted into -$83.5M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-4.46, tying the income statement back to per-share earnings.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 8-K | Current report | Nov 5, 2026 | |
| 10-Q | Quarterly report | Nov 5, 2026 | |
| SC 13G/A | SC 13G/A filing | Oct 29, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 28, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 2, 2026 |
How much revenue does TECX generate?
Tectonic Therapeutic, Inc. (TECX) reported $0.00 of revenue in fiscal 2025.
Is TECX profitable?
Tectonic Therapeutic, Inc. (TECX) reported -$74.15M of net income.
Continue the stock analysis
Jump to another research area for this company.